Share price base is going up. 3 year graph looks good. Avax is holding steady with a good incline. Turning around an old well preserved ship takes time. Data should be coming out soon for OVAX Phase 1/2 CTCA trial. CEO is attending Biotech Showcase meetings. Any loyal science proficient shareholders who might be interested in helping privately re-capitalize the Company should contact the CEO directly.
News 
Market Data 
Discover 
